1. [P2–083]: THE EFFECTS OF A NOVEL NON‐CATECHOL DOPAMINE PARTIAL AGONIST ON WORKING MEMORY IN THE AGED RHESUS MONKEY. (1st July 2017) Authors: Moore, Tara L.; Smith, Rebecca; Bowley, Bethany; Killiany, Ronald; Volfson, Dmitri; Gray, David L.; Fonseca, Kari R.; Shamblin, Sheri I.; Kozak, Rouba Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 13 Page Start: P638 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [P3–046]: NOVEL NON‐CATECHOL D1 RECEPTOR AGONISTS EXHIBIT SUSTAINED PHARMACOLOGICAL ACTIVITY. (1st July 2017) Authors: Tierney, Patrick L.; Allen, John A.; Volfson, Dmitri; Lotarski, Susan; Rossi, Amie; Gray, David L.; Kozak, Rouba Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 19 Page Start: P947 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Continuous gait monitoring discriminates community‐dwelling mild Alzheimer's disease from cognitively normal controls. Issue 1 (5th February 2021) Authors: Varma, Vijay R.; Ghosal, Rahul; Hillel, Inbar; Volfson, Dmitri; Weiss, Jordan; Urbanek, Jacek; Hausdorff, Jeffrey M.; Zipunnikov, Vadim; Watts, Amber Journal: Alzheimer's & dementia Issue: Volume 7:Issue 1(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Continuous Monitoring Using a Wearable Device Detects Activity‐Induced Heart Rate Changes After Administration of Amphetamine. Issue 6 (27th September 2019) Authors: Izmailova, Elena S.; McLean, Ian L.; Hather, Greg; Merberg, David; Homsy, Jason; Cantor, Matthew; Volfson, Dmitri; Bhatia, Gaurav; Perakslis, Eric D.; Benko, Christopher; Wagner, John A. Journal: Clinical and translational science Issue: Volume 12:Issue 6(2019) Page Start: 677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P4‐234: IMPROVED VASCULAR REACTIVITY AND REDUCED CEREBRAL AMYLOID ANGIOPATHY FOLLOWING PASSIVE IMMUNOTHERAPY IN TRANSGENIC MICE. (1st July 2014) Authors: Bales, Kelly; O'Neill, Sharon; Pozdnyakov, Nikolay; Pan, Feng; Caouette, David; Pi, YeQing; Wood, Kathleen M.; Volfson, Dmitri; Cirrito, John; Han, Byung Hee; Johnson, Andrew; Zipfel, Gregory; Samad, Tarek Journal: Alzheimer's & dementia Issue: Volume 10:Supplement 4S(2014)Part 15 Page Start: P872 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P4‐315: Evaluating amyloid‐beta processing using novel gamma‐secretase modulators in preclinical animal models. (1st July 2015) Authors: Wood, Kathleen M.; Gonzales, Cathleen; Pan, Feng; Pozdnyakov, Nikolay; Marconi, Michael; Robshaw, Ashley; Riddell, David; Volfson, Dmitri; Pettersson, Martin; Hajos-Korcsok, Eva; Bales, Kelly R. Journal: Alzheimer's & dementia Issue: Volume 11(2015)Supplement 7:Part 19 Page Start: P905 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivity. (22nd October 2015) Authors: Bales, Kelly R.; O'Neill, Sharon M.; Pozdnyakov, Nikolay; Pan, Feng; Caouette, David; Pi, YeQing; Wood, Kathleen M.; Volfson, Dmitri; Cirrito, John R.; Han, Byung-Hee; Johnson, Andrew W.; Zipfel, Gregory J.; Samad, Tarek A. Journal: Brain Issue: Volume 139:Part 2(2016:Feb.) Page Start: 563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacological evaluation of clinically relevant concentrations of (2R, 6R)-hydroxynorketamine. (15th July 2019) Authors: Shaffer, Christopher L.; Dutra, Jason K.; Tseng, Wei Chou; Weber, Mark L.; Bogart, Luke J.; Hales, Katherine; Pang, Jincheng; Volfson, Dmitri; am Ende, Christopher W.; Green, Michael E.; Buhl, Derek L. Journal: Neuropharmacology Issue: Volume 153(2019) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety, pharmacokinetics and quantitative EEG modulation of TAK‐071, a novel muscarinic M1 receptor positive allosteric modulator, in healthy subjects. Issue 2 (31st July 2021) Authors: Yin, Wei; Mamashli, Fahimeh; Buhl, Derek L.; Khudyakov, Polyna; Volfson, Dmitri; Martenyi, Ferenc; Gevorkyan, Hakop; Rosen, Laura; Simen, Arthur A. Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 2(2022) Page Start: 600 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗